25
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Localized thermo-cisplatin therapy: A pilot study in spontaneous canine and feline tumours

, , , &
Pages 881-892 | Received 01 Oct 1990, Accepted 12 Apr 1991, Published online: 09 Jul 2009

References

  • Alberts D. S., Peng Y-M., Chen H. S. G., Moon T. E., Cetas T. S., Hoeschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. Journal of the National Cancer Institute 1980; 65: 455–461
  • Arcangeli G., Cividalli A., Lovisolo G., Mauro F., Creton G., Nervi E., Ravin G. Effectiveness of local hyperthermia in association with radiotherapy or chemotherapy: Comparison of multimodality treatments on multiple neck node metastases. Proceedings, First Meeting of European Group on Hyperthermia in Radiation Oncology. 1979; 257
  • Barlogie B., Cory P. M., Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(ii) and mitomycin-C. Cancer Research 1980; 40: 1165–1166
  • Begg A. C., Bartelink H., Stewart F. A., Brown D. M., Luck E. E. Improvement of differential toxicity betwen tumor and normal tissues using intratumoral injection with and without a slow-drug-release matrix system. National Cancer Institute Monograph 1988; 6: 133–136
  • Daniels J. R., Sternlicht M., Daniels A. Collagen chemoembolization: Pharma-cokinetics and tissue tolerance of cis-diamminedichloroplatinum(ii) in porcine liver and rabbit kidney. Cancer Research 1988; 48: 2446–2450
  • Fischer G. A., Hahn G. M. Enhancement of cis-diamminedichloroplatinum (cisplatin) cytotoxicity by hyperthermia. National Cancer Institute Monograph 1982; 61: 255–257
  • Gahan M. C., Tyczkowska K. The determination of platinum in biological materials by electrothermal atomic absorption spectroscopy. Spectrochimica Am. 1987; 42B: 665–668
  • Gerard H., Egorin M. J., Whitacre M., Van Echo D. A., Aisner J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum (ii) and whole-body hyperthermia. Cancer Chemotherapy and Pharmacology 1983; 11: 162–166
  • Green D. M., Burton G. V., Cox E. B., Hanson D., Moore J., Oleson J. R. A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy. International Journal of Hyperthermia 1989; 5: 13–21
  • Herman T. S., Teicher B. A., Collins L. S. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures. Cancer Research 1988; 48: 2342–2347
  • Herman T. S., Van Kersen I., Hahn G., Montoya V., Luck E., Brown D. Effect of localized hyperthermia in combination with matrix-associated chemotherapy in vivo. Proceedings, 34th Annual Meeting of the Radiation Research Society, Las Vegas, 1986; 21
  • Herman T. S., Zukoski C. F., Anderson R. M., Hutter J. J., Blitt C. D., Malone J. M., Larson D. F., Dean J. C., Roth H. B. Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies. Cancer Treatment Report 1982; 66: 259–265
  • Kodama K., Doi O., Tatsuta M., Kuriyama K., Tateishi R. Development of postoperative intrathoracic chemo-thermotherapy for lung cancer with objective of improving local cure. Cancer 1989; 64: 1422–1428
  • Krag D. N., Théon A. P., Schneider P. D., Goodnight J. E. Intralesional cis-diamminedichloroplatinum and purified collagen treatment of human metastatic malignancies: A feasibility study. Journal of Surgical Oncology 1990; 43: 83–87
  • Li D. G., Hou B. S. Preliminary report on the treatment of esophageal cancer by intraluminal microwave hyperthermia and chemotherapy. Cancer Treatment report 1987; 71: 1013–1019
  • Litterst C. L., Gram T. E., Dedrick R. L., Leroy A. F., Guarino A. M. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(ii) (NSC 119875) to dogs. Cancer Research 1976; 36: 2340–2344
  • Madewell B. R., Theilen G. H. Tumors of the skin and subcutaneous tissues. Veterinary Cancer Medicine, G. H. Theilen, B. R. Madewell. Lea & Febiger, Philadelphia, PA 1987; 233
  • Mansouri A., Henle K. J., Benson A. M., Moss A. J., Nagle W. A. Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia. Cancer Research 1989; 49: 2674–2678
  • Marmor J. B. Interactions of hyperthermia and chemotherapy in animals. Cancer Research 1979; 39: 2269–2276
  • Mella O. Combined hyperthermia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4A tumors. International Journal of Hyperthermia 1985; 1: 171–183
  • Merlano M., Esposito M., Fulco R. A., Benasso M., Rosso R. Topical administration of cisplatin in far-advanced squamous cell carcinoma of the head and neck. European Journal of Cancer and Clinical Oncology 1986; 22: 119–120
  • Meyn R. E., Corry P. M., Fletcher S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloro-platinum(ii). Cancer Research 1980; 40: 1136–1139
  • Murthy M. S., Khandekar J. D., Travis J. D., Scanlon E. F. Combined effects of hyperthermia and platinum compounds in vivo and in vitro on murine and human tumor cells. Hyperthermic Oncology, Summary papers, J. Overgaard. Taylor & Francis, London 1984; Vol. 1: 421–424
  • Nagase M., Nomura T., Nakajima T. Effects of intralesional versus ip. administration of cisplatin on squamous cell carcinoma of mice. Cancer Treatment Report 1987; 71: 825–829
  • Neilan B. A., Henle K. J., Nagle W. A., Moss A. J. Cytotoxicity of hyperthermia combined with bleomycin or cisplatinum in cultured RIF cells: modification by thermotolerance and by polyhydroxy compounds. Cancer Research 1986; 46: 2245–2247
  • TNM Classification of Tumours in Domestic Animals, 1st edn, L. N. Owen. World Health Organization, Geneva 1980
  • Penn R. D., Kroin J. S., Harris J. E., Chiu K. M., Braun D. P. Chronic intratumoral chemotherapy of a rat tumor with cisplatin and fluorouracil. Applied Neurophysiology 1983; 46: 240–244
  • Pommier R. F., Moseley H. S., Cohen J., Huang C. S., Townsend R., Fletcher W. S. Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated perfusion for soft-tissue sarcoma and melanoma of the extremities. American Journal of Surgery 1988; 155: 667–671
  • Sapozink M. D., Cetas T., Corry P. M., Egger M. J., Fessenden P. Introduction to hyperthermia device evaluation. International Journal of Hyperthermia 1988; 4: 1–15
  • Wallner K. E., Li G. C. Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin-C and cisplatin. Cancer Research 1987; 47: 493–495
  • Wallner K. E., DeGregorio M. W., Li G. C. Hyperthermic potentiation of cis-diamminedichloroplatinum(ii) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Research 1986; 46: 6242–6245
  • Wondergem J., Bulger R. E., Siddik Z. H., Leygraaf J-W., Strebel F. R., Alonso M., Travis E. L., Bull J. M. C. A comparison of thermal enhancement of cis-diamminedichloroplatinum(ii) induced renal and intestinal toxicities by whole body hyperthermia in the rat. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1551–1556

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.